Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
98.85
+4.25 (4.50%)
Nov 21, 2024, 3:49 PM EST - Market open
Axsome Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4,790 | 3,766 | 3,349 | 1,424 | 3,042 | 3,805 | |
| Market Cap Growth | 30.79% | 12.44% | 135.22% | -53.20% | -20.03% | 4425.27% | |
| Enterprise Value | 4,449 | 3,535 | 3,216 | 1,359 | 2,888 | 3,781 | |
| Last Close Price | 94.60 | 79.59 | 77.13 | 37.78 | 81.47 | 103.36 | |
| PS Ratio | 13.31 | 13.92 | 66.94 | - | - | - | |
| PB Ratio | 49.32 | 19.72 | 30.57 | 91.10 | 26.74 | 21.29 | |
| P/TBV Ratio | 133.33 | 29.97 | 84.61 | 91.10 | 26.74 | 21.29 | |
| EV/Sales Ratio | 13.15 | 13.06 | 64.28 | - | - | - | |
| Debt / Equity Ratio | 2.07 | 0.98 | 0.86 | 3.18 | 0.44 | 0.11 | |
| Asset Turnover | 0.58 | 0.59 | 0.24 | - | - | - | |
| Inventory Turnover | 2.49 | 2.68 | - | - | - | - | |
| Quick Ratio | 2.30 | 3.46 | 2.47 | 3.75 | 7.85 | 8.98 | |
| Current Ratio | 2.44 | 3.63 | 2.54 | 3.75 | 7.85 | 9.00 | |
| Return on Equity (ROE) | -171.61% | -159.21% | -298.97% | -201.51% | -70.36% | -76.08% | |
| Return on Assets (ROA) | -26.44% | -24.86% | -52.29% | -56.91% | -30.46% | -35.55% | |
| Return on Capital (ROIC) | -41.52% | -39.31% | -81.33% | -68.00% | -34.16% | -40.62% | |
| Earnings Yield | -6.75% | -6.35% | -5.59% | -9.16% | -3.38% | -1.80% | |
| FCF Yield | -2.88% | -3.87% | -3.50% | -7.62% | -2.58% | -1.22% | |
| Buyback Yield / Dilution | -7.10% | -11.73% | -8.07% | -1.11% | -9.37% | -26.55% | |
| Total Shareholder Return | -7.10% | -11.73% | -8.07% | -1.11% | -9.37% | -26.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.